Technical Analysis for ORGS - Orgenesis Inc.

Grade Last Price % Change Price Change
grade D 5.56 2.02% 0.11
ORGS closed up 2.02 percent on Wednesday, August 5, 2020, on 16 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Flat
Historical ORGS trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
MACD Bullish Signal Line Cross Bullish 2.02%
Bollinger Band Squeeze Range Contraction 2.02%
NR7 Range Contraction 2.02%
Lower Bollinger Band Walk Weakness 2.02%
BB Squeeze + Lower Band Touch Range Contraction 2.02%
Lower Bollinger Band Touch Weakness 2.02%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Orgenesis Inc. is a regenerative therapy company. The Company operates through two segments: Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CTB). The CDMO activity is operated by the Company's subsidiary, MaSTherCell SA, which specializes in cell therapy development for advanced medicinal products. MaSTherCell is providing two types of services to its customers: process and assay development services and good manufacturing practice (GMP) contract manufacturing services. The CTB activity is based on its technology that demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and differentiating (converting) them into pancreatic beta cell-like insulin producing cells for patients with Type I Diabetes. It intends to advance a product that combines cell-based therapy and regenerative medicine, Autologous Insulin Producing (AIP) cells, into clinical development.
Biotechnology Diabetes Stem Cells Endocrine System Hormones Regenerative Medicine Cell Therapy Insulin Peptide Hormones Contract Manufacturing Services Diabetes Mellitus Type 1 Manufacturing Practice Medicinal Products

Is ORGS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 8.2
52 Week Low 2.4
Average Volume 152,503
200-Day Moving Average 4.78
50-Day Moving Average 6.35
20-Day Moving Average 5.67
10-Day Moving Average 5.54
Average True Range 0.37
ADX 13.18
+DI 16.65
-DI 15.67
Chandelier Exit (Long, 3 ATRs ) 5.27
Chandelier Exit (Short, 3 ATRs ) 6.27
Upper Bollinger Band 6.01
Lower Bollinger Band 5.33
Percent B (%b) 0.34
BandWidth 11.86
MACD Line -0.21
MACD Signal Line -0.22
MACD Histogram 0.0119
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.80
Resistance 3 (R3) 5.79 5.71 5.76
Resistance 2 (R2) 5.71 5.65 5.71 5.75
Resistance 1 (R1) 5.63 5.61 5.67 5.64 5.73
Pivot Point 5.55 5.55 5.57 5.55 5.55
Support 1 (S1) 5.47 5.49 5.51 5.48 5.39
Support 2 (S2) 5.39 5.45 5.39 5.37
Support 3 (S3) 5.31 5.39 5.36
Support 4 (S4) 5.32